GlycoNAVI: CheGly (Chemical Glycosylation)
ACT

Cleistetroside-6

ID Compound Name Target Name Species Assay Method Activity Value Conditions DOI
act2231Cleistetroside-6E. coli MG1655MIC (μM)>6410.1021/ml300303g
act2239Cleistetroside-6E. coli impMIC (μM)>6410.1021/ml300303g
act2247Cleistetroside-6B. subtilis JH642MIC (μM)410.1021/ml300303g
act2255Cleistetroside-6NCI-H460MIC (μM)7.510.1021/ml300303g
act2261Cleistetroside-6RPMI-8226 (leukemia)GI50 (μM)0.9610.1021/ml300303g
act2267Cleistetroside-6SR (leukemia)GI50 (μM)0.8610.1021/ml300303g
act2273Cleistetroside-6A549 (nonsmall cell lung cancer)GI50 (μM)1.1810.1021/ml300303g
act2279Cleistetroside-6NCI-H460 (nonsmall cell lung cancer)GI50 (μM)0.9410.1021/ml300303g
act2285Cleistetroside-6HCT-15 (colon cancer)GI50 (μM)1.0110.1021/ml300303g
act2291Cleistetroside-6HT-29 (colon cancer)GI50 (μM)0.9710.1021/ml300303g
act2297Cleistetroside-6SF-539 (CNS cancer)GI50 (μM)0.8310.1021/ml300303g
act2303Cleistetroside-6SNB-75 (CNS cancer)GI50 (μM)0.5010.1021/ml300303g
act2309Cleistetroside-6MDA-MB-435 (melanoma)GI50 (μM)0.8310.1021/ml300303g
act2315Cleistetroside-6SK-MEL-5 (melanoma)GI50 (μM)0.7410.1021/ml300303g
act2321Cleistetroside-6OVCAR-3 (ovarian cancer)GI50 (μM)0.7710.1021/ml300303g
act2327Cleistetroside-6ADR-R (ovarian cancer)GI50 (μM)3.3810.1021/ml300303g
act2333Cleistetroside-6A498 (renal cancer)GI50 (μM)0.7310.1021/ml300303g
act2339Cleistetroside-6CAKI-1 (renal cancer)GI50 (μM)1.4210.1021/ml300303g
act2345Cleistetroside-6PC-3 (prostate cancer)GI50 (μM)0.8210.1021/ml300303g
act2351Cleistetroside-6DU-145 (prostate cancer)GI50 (μM)0.8010.1021/ml300303g
act2357Cleistetroside-6MCF7 (breast cancer)GI50 (μM)0.8710.1021/ml300303g
act2363Cleistetroside-6BT-549 (breast cancer)GI50 (μM)0.9410.1021/ml300303g